Edwards Lifesciences Financial Diagnostics

Edwards Lifesciences Corporation -- USA Stock  

USD 120.49  0.42  0.35%

Edwards Lifesciences Corporation diagnostics interface makes it easy to digest most current publicly released information about Edwards Lifesciences as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Edwards Lifesciences price relationship with some important fundamental indicators such as market cap and management efficiency.
The company has Price/Earnings To Growth (PEG) ratio of 1.94. Edwards Lifesciences Corporation had not issued any dividends in recent years. This company had 2:1 split on 2015-12-14. Edwards Lifesciences Corporationration offer solutions and technologies to treat structural heart disease and critically ill patients worldwide. To learn more about EDWARDS LIFESCIEN call Michael Mussallem at 949 250-2500 or check out www.edwards.com.

Edwards Lifesciences Alerts

Edwards Lifesciences has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its debt commitments
Latest headline from www.dispatchtribunal.com: Belpointe Asset Management LLC Invests 354000 in Edwards Lifesciences Corp

Edwards Lifesciences Upcoming Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017

Edwards Lifesciences EPS Estimate

EPSEstimate Date
Quarterly Estimate0.83April 25, 2017

Edwards Lifesciences SEC Filings

Financial Statements and Exhibits. Results of Operations and Financial Condition
Unclassified Corporate Event
Financial Statements and Exhibits. Departure of Directors or Certain Offices; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event

Institutional Investors

Security TypeSharesValue
Bank Of MontrealCommon Shares235.9 K26.6 M
Factory Mutual Insurance CoCommon Shares211.3 K23.8 M
Vontobel Asset Management IncCommon Shares182.5 K20.6 M
Nisa Investment Advisors LlcCommon Shares97.6 K11 M
Oregon Public Employees Retirement FundCommon Shares53.5 K6 M
Country Trust BankCommon Shares37.6 K4.2 M
Exxonmobil Investment Management IncCommon Shares33.6 K3.8 M

Market Capitalization

The company currently falls under 'Large-Cap' category with market capitalization of 25.39 B.

Profitablity

The company has Net Profit Margin (PM) of 22.47 % which may suggest that it has a good control over its expenditures, executes well on its competitive polices, or have a solid pricing strategies. This is very large. Likewise, it shows Net Operating Margin (NOM) of 29.97 % which signify that for every $100 of sales it has a net operating income of 0.3.

Management Efficiency

Edwards Lifesciences Corporation has Return on Asset (ROA) of 12.64 % which means that for every $100 of asset it generated profit of $12.64. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 25.45 % which means that it produced $25.45 on every 100 dollars invested by current stockholders.

Stock Holders for Edwards Lifesciences

Information
Ratio
Value
At Risk
BairdBaird MidCap Inst(0.16) (0.9) 
NASDAQ NNASDAQ N America Large Mid Cap(0.27) (0.88) 
WSCMXWellington Shields All Cap A 0.0647 (0.48) 
WellsWells Fargo Enterprise Inst 0.0297 (0.51) 
WellsWells Fargo Enterprise R6 0.0304 (0.51) 
WellsWells Fargo Enterprise C 0.0208 (0.51) 
VanguardVanguard Mid Cap Growth Index Admiral(0.0966) (0.61) 
VanguardVanguard Mid Cap Growth Index Investor(0.0958) (0.61) 
VanguardVanguard Mid Cap Index InstitutionalPlus(0.11) (0.6) 
VanguardVanguard Mid Cap Index Institutional(0.11) (0.59) 
VanguardVanguard Mid Cap Index Investor(0.11) (0.59) 
VanguardVanguard Mid Cap Index Admiral(0.11) (0.6) 
TaylorTaylor Frigon Core Growth Fund(0.037) (0.9) 
SUFCXGuggenheim StylePlus Mid Growth C(0.21) (0.74) 
SSQSSQ Hillsdale U S Equity GIF Premium(0.1) (1) 
SEUPXGuggenheim StylePlus Mid Growth P(0.2) (0.73) 
WellsWells Fargo Enterprise Admin 0.0278 (0.51) 
WellsWells Fargo Enterprise A 0.0272 (0.5) 
SECUXGuggenheim StylePlus Mid Growth A(0.2) (0.73) 
RWGIXRiverParkWedgewood Institutional(0.19) (0.56) 

Technical Drivers

Edwards Lifesciences Corporation shows Coefficient Of Variation of 426.24, Mean Deviation of 0.8435 and Downside Deviation of 0.8265. Edwards Lifesciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Edwards Lifesciences Corporation which can be compared to its rivals. Please confirm Edwards Lifesciences Information Ratio, Potential Upside as well as the relationship between Potential Upside and Kurtosis to decide if Edwards Lifesciences is priced favorably providing market reflects its regular price of 120.49 per share. Given that Edwards Lifesciences has Jensen Alpha of 0.1074, we urge you verify Edwards Lifesciences Corporation prevailing market performance to make sure the company can sustain itself at future point.

Edwards Lifesciences Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
  
Execute Study
 
The output start index for this execution was thirteen with a total number of output elements of four. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Edwards Lifesciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Edwards Lifesciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Stakeholder Activities

Edwards Lifesciences Insider Trading
Patrick Verguet a day ago via Macroaxis 
Sale by Patrick Verguet of 2000 shares of Edwards Lifesciences
Redmond Paul C few days ago via Macroaxis 
Exercise or conversion by Redmond Paul C of 17200 shares of Edwards Lifesciences subject to Rule 16b-3
Donald Bobo few days ago via Macroaxis 
Sale by Donald Bobo of 4919 shares of Edwards Lifesciences
Michael Mussallem over a week ago via Macroaxis 
Exercise or conversion by Michael Mussallem of 32800 shares of Edwards Lifesciences subject to Rule 16b-3
Bowlin Michael R over two weeks ago via Macroaxis 
Exercise or conversion by Bowlin Michael R of 10000 shares of Edwards Lifesciences subject to Rule 16b-3
Michael Mussallem over two weeks ago via Macroaxis 
Exercise or conversion by Michael Mussallem of 40000 shares of Edwards Lifesciences subject to Rule 16b-3
Garren Bruce P over three weeks ago via Macroaxis 
Exercise or conversion by Garren Bruce P of 430 shares of Edwards Lifesciences subject to Rule 16b-3
Larry Wood over three weeks ago via Macroaxis 
Exercise or conversion by Larry Wood of 18960 shares of Edwards Lifesciences subject to Rule 16b-3
Larry Wood over a month ago via Macroaxis 
Exercise or conversion by Larry Wood of 18960 shares of Edwards Lifesciences subject to Rule 16b-3
Michael Mussallem over a month ago via Macroaxis 
Edwards Lifesciences exotic insider transaction detected
Michael Mussallem over a month ago via Macroaxis 
Edwards Lifesciences exotic insider transaction detected
Solomon Carlyn D over a month ago via Macroaxis 
Acquisition by Solomon Carlyn D of 4100 shares of Edwards Lifesciences subject to Rule 16b-3

Bonds

Edwards Lifesciences Outstanding Bonds

Corporate Filings

Edwards Lifesciences Corporate Reports
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations